548 Results

People

  1. Rossi
    Rossi
  2. Dee
    Dee
  3. Marghoob
    Marghoob
  4. Dogan
    Dogan
  5. Dusza
    Dusza
  6. Giralt
    Giralt
  7. Perales
    Perales
  8. Marchetti
    Marchetti
  9. Nehal
    Nehal
  10. Salles
    Salles

Groups

  1. Department of Medicine (301)
  2. Hematologic Malignancies, Division of (169)
  3. Center for Hematologic Malignancies (151)
  4. Sloan Kettering Institute Postdocs (133)
  5. Survivorship Research (132)
  6. Division of Subspecialty Medicine (121)
  7. Population Sciences Research Program (116)
  8. GSK Faculty (96)
  9. Dermatology Service (87)
  10. Dermatology (86)
  1. "Research letter"
Formats
  1. Research Letter (548)
Groups
  1. Department of Medicine (301)
  2. Hematologic Malignancies, Division of (169)
  3. Center for Hematologic Malignancies (151)
  4. Sloan Kettering Institute Postdocs (133)
  5. Survivorship Research (132)
  6. Division of Subspecialty Medicine (121)

More Groups

People
  1. Anthony Rossi (23)
  2. Edward Christopher Dee (21)
  3. Ashfaq Marghoob (19)
  4. Ahmet Dogan (18)
  5. Michael Marchetti (18)
  6. Miguel-Angel Perales (17)

More People

Years
  1. 2025 (42)
  2. 2024 (89)
  3. 2023 (101)
  4. 2022 (82)
  5. 2021 (91)
  6. 2020 (95)

More Years

Publications
  1. Journal of the American Academy of Dermatology (46)
  2. Blood Advances (31)
  3. Haematologica (25)
  4. Leukemia (25)
  5. Bone Marrow Transplantation (18)
  6. American Journal of Hematology (17)

More Publications

Publishers
  1. Nature Publishing Group (97)
  2. Mosby Elsevier (49)
  3. American Medical Association (45)
  4. American Society of Hematology (44)
  5. Wiley Blackwell (34)
  6. Elsevier Inc. (29)

More Publishers

Results (548)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: A real-world observational study in the United States
    Research Letter

    Hultcrantz, M.; Kleinman, D.; Vij, R.; Escalante, F.; Delforge, M.; Kotowsky, N.; Bitetti, J.; Boytsov, N.; Camadoo-O’Byrne, L.; Happ, L. P.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma
    Research Letter

    Dileo, R.; Mewawalla, P.; Babu, K.; Yin, Y.; Strouse, C.; Chen, E.; Shaikh, H.; Davis, J. A.; Green, K. M.; Alkharabsheh, O.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL
    Research Letter

    Kittai, A. S.; Huang, Y.; Miller, S.; Allan, J. N.; Bhat, S. A.; Bond, D. A.; Brander, D. M.; Byrd, J. C.; Chavez, J. C.; Chong, E.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • BTK inhibitors versus venetoclax as first- or second-line therapy in chronic lymphocytic leukemia/small lymphocytic lymphoma: A real-world evidence study
    Research Letter

    Roeker, L. E.; Han, Y.; Teschemaker, A.; Mato, A. R.; Thompson, M. C.
    American Journal of Hematology (2025)

    Fulltext@MSK | Save
  • Cell-free circulating tumor DNA for noninvasive molecular profiling among patients undergoing definitive chemoradiation for locally advanced lung cancer
    Research Letter

    Lebow, E. S.; Eichholz, J.; Boe, L.; Zhang, Z.; Kratochvil, L. B.; Gelblum, D. Y.; Simone, C. B. 2nd; Shepherd, A. F.; Iyengar, P.; Shin, J. Y.; more...
    Advances in Radiation Oncology (2025)

    Fulltext@MSK | Save
  • Local therapy for isolated central nervous system progression among patients receiving antibody-drug conjugate therapy
    Research Letter

    Lebow, E. S.; Eichholz, J.; Zhang, Z.; Toumbacaris, N.; Imber, B.; Chen, L.; LaPlant, Q.; Yamada, J.; Pike, L. R. G.; Modi, S.; more...
    Advances in Radiation Oncology (2025)

    Fulltext@MSK | Save
  • Severe toxicity, but long-term persistence of CAR T cells after immune checkpoint inhibitors in large B-cell lymphoma
    Research Letter

    Deschenes-Simard, X.; Pennisi, M.; Perales, M. A.; Shah, G. L.; Zelenetz, A. D.; Yahalom, J.; Imber, B. S.; Santomasso, B. D.; Dahi, P. B.
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes
    Research Letter

    Stuver, R.; Dusza, S.; Epstein-Peterson, Z. D.; Ghione, P.; Horwitz, S. M.; Johnson, W.; Moskowitz, A. J.; Myskowski, P.; Pulitzer, M.; Geller, S.
    Journal of the European Academy of Dermatology and Venereology (2025)

    Fulltext@MSK | Save
  • Treatment effectiveness of venetoclax-based therapy after Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: An International Real-World Study
    Research Letter

    Ghosh, N.; Eyre, T. A.; Brown, J. R.; Lamanna, N.; Manzoor, B. S.; Coombs, C. C.; Tuncer, H. H.; Ujjani, C.; Leslie, L. A.; Roeker, L. E.; more...
    American Journal of Hematology (2025)

    Fulltext@MSK | Save
  • Effect of mannitol on cisplatin-associated acute kidney injury: A target trial emulation
    Research Letter

    Gupta, S.; Glezerman, I. G.; Hirsch, J. S.; Wells, S. L.; Chen, K. L.; Seitter, R. H.; Monson, A. E.; Green-Lingren, O.; Jhaveri, K. D.; Page, V. D.; more...
    Nephrology Dialysis Transplantation (2025)

    Fulltext@MSK | Save